Potential to induce lamellar bodies and acute cytotoxicity of 6′-alkyl analogues of spectinomycin in primary cultures of rat hepatocytes-Reference-Cited by-同舟云学术

Potential to induce lamellar bodies and acute cytotoxicity of 6′-alkyl analogues of spectinomycin in primary cultures of rat hepatocytes

Published:1991-01 Issue:3 Volume:5 Page:239-245
ISSN:0887-2333
Container-title:Toxicology in Vitro
language:en
Short-container-title:Toxicology in Vitro

Author:

Ulrich R.G.,Cramer C.T.

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference22 articles.

1. Distribution and disposition of trospectomycin sulfate in the rat, perfused rat liver, and cultured rat hepatocytes;Cox;Drug Metabolism and Disposition,1990

2. Acute hepatocellular effects of erythromycin, gentamicin, and trospectomycin in the perfused rat liver: lack of correlation between lamellar body induction potency and cytotoxicity;Cox;Pharmacology and Toxicology,1988

3. Reversible, hepatic, lysosomal phospholipidosis in rat induced by subchronic daily administration of trospectomycin sulfate;Cox;Biochemical Pharmacology,1989

4. An ultrathin sectioning alignment tool with application to cell monolayers;Cramer;Journal of Electron Microscopy Techniques,1989

5. Preparation of primary cultures of rat hepatocytes suitable for in vitro toxicity testing;Elliget;Journal of Tissue Culture Methods,1983

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic ultrastructural alterations induced by copper oxide nanoparticles: In vivo electron microscopy study;Toxicology and Industrial Health;2023-10-03

2. Ultrastructural hepatocytic alterations induced by silver nanoparticle toxicity;Ultrastructural Pathology;2016-03-02

3. Ultrastructural Hepatic Alterations Induced by 35 nm Zinc Oxide Nanoparticles;Nanoscience and Nanotechnology Letters;2015-09-01

4. High content screening analysis of phospholipidosis: Validation of a 96-well assay with CHO-K1 and HepG2 cells for the prediction of in vivo based phospholipidosis;Toxicology in Vitro;2011-12

5. Drug-induced phospholipidosis: issues and future directions;Expert Opinion on Drug Safety;2006-06-15